Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients.

Show simple item record

dc.contributor.author Zolezzi, Monica en
dc.contributor.author Abdallah, Oraib en
dc.contributor.author Kheir, Ahmed en
dc.contributor.author Abdelsalam, Abdelsalam Gomaa en
dc.date.accessioned 2018-10-17T20:25:59Z en
dc.date.issued 2019-03 en
dc.identifier.issn 1551-7411 en
dc.identifier.uri http://hdl.handle.net/2292/42645 en
dc.description.abstract BACKGROUND:Individuals who suffer from major cardiovascular events every year have one or more risk factors. Cardiovascular disease (CVD) risk assessment is an important strategy for the early identification of modifiable risk factors and their management. There is substantial evidence that shifting the focus from treatment to primary prevention reduces the burden of CVD. OBJECTIVES:To evaluate the preparedness of community pharmacists in Qatar for the provision of CVD risk assessment and management services; and to explore the pharmacists' views on the provision of these services. METHODS:A cross-sectional study using simulated-client methodology. Using standardized scenarios, community pharmacists were approached for consultation on two medicines (Aspirin® and Crestor®) used for managing specific CVD risk factors. Pharmacists' competency to assess CVD risk was the primary outcome evaluated. Scores for each outcome were obtained based on the number of predefined statements addressed during the consultation. RESULTS:The mean cumulative score for all the competency outcomes assessed was 11.7 (SD 3.7) out of a possible score of 31. There were no differences for the majority of the competencies tested between the two scenarios used. Significantly more pharmacists exposed to the Aspirin® scenario than to the Crestor® scenario addressed hypertension as one of the risk factors needed to assess CVD risk (22% versus 11%, p = 0.03); whereas significantly more pharmacists in the Crestor® scenario compared to the Aspirin® scenario, addressed dyslipidemia as one of the risk factors needed to assess CVD risk (30% versus 7%, p = 0.02). Significantly more pharmacists exposed to the Aspirin® scenario provided explanation about CVD risk than those exposed to the Crestor® scenario 36% versus 8%, p < 0.01). CONCLUSION:The results suggest that many community pharmacists in Qatar are not displaying competencies that are necessary for the provision of CVD prevention services. en
dc.format.medium Print-Electronic en
dc.language eng en
dc.relation.ispartofseries Research in social & administrative pharmacy : RSAP en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.subject Humans en
dc.subject Cardiovascular Diseases en
dc.subject Aspirin en
dc.subject Risk Assessment en
dc.subject Professional Role en
dc.subject Primary Prevention en
dc.subject Clinical Competence en
dc.subject Patient Simulation en
dc.subject Adult en
dc.subject Middle Aged en
dc.subject Pharmacists en
dc.subject Community Pharmacy Services en
dc.subject Qatar en
dc.subject Female en
dc.subject Male en
dc.subject Rosuvastatin Calcium en
dc.title Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients. en
dc.type Journal Article en
dc.identifier.doi 10.1016/j.sapharm.2018.04.032 en
pubs.issue 3 en
pubs.begin-page 252 en
pubs.volume 15 en
dc.rights.holder Copyright: The author en
dc.identifier.pmid 29753643 en
pubs.end-page 259 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Research Support, Non-U.S. Gov't en
pubs.subtype Journal Article en
pubs.subtype Observational Study en
pubs.elements-id 740424 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Pharmacy en
dc.identifier.eissn 1934-8150 en
pubs.record-created-at-source-date 2018-05-14 en
pubs.dimensions-id 29753643 en


Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics